About ALPHA COGNITION USA, INC.
Alpha Cognition Inc. is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases such as Alzheimer's and Cognitive Impairment with mild Traumatic Brain Injury. Their drug ZUNVEYL (benzgalantamine) is approved for the treatment of mild to moderate dementia of the Alzheimer's type in adults.
Is this your company?
Claim ALPHA COGNITION USA, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim ALPHA COGNITION USA, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.